Literature DB >> 20010723

A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide.

Changgui Li1, Bozena Jaentschke, Yingli Song, Junzhi Wang, Terry D Cyr, Gary Van Domselaar, Runtao He, Xuguang Li.   

Abstract

The fusion peptide of influenza virus hemagglutinin (HA) has a critical role in mediating the entry of the virus into the cells and is also the only universally conserved sequence in the HAs of all strains of influenza A and influenza B viruses. Therefore, it could be an attractive target for new vaccine development and a potency marker for existing influenza vaccines. The fusion peptide epitope is hidden inside the HA proteins, making it inaccessible for quantitative antibody binding. Our simple slot blot protocol highlights pre-treatment of HA samples with moderate concentrations of denaturant to maximally expose the fusion peptide on the protein surface, followed by detection using universal antibodies targeting the fusion peptide. The method is highly reliable, inexpensive and easy to follow. The entire procedure takes only 5 h and can be applied to the quantitative determination of virtually all influenza viral HAs using a single antibody targeting the fusion peptide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20010723     DOI: 10.1038/nprot.2009.200

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  20 in total

1.  The influence of the host cell on standardisation of influenza vaccine potency.

Authors:  J M Wood; U Dunleavy; R W Newman; A M Riley; J S Robertson; P D Minor
Journal:  Dev Biol Stand       Date:  1999

Review 2.  Influenza vaccines: a review and rationale for use in developed and underdeveloped countries.

Authors:  G A Poland; S T Rottinghaus; R M Jacobson
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

3.  Ultra performance liquid chromatography isotope dilution tandem mass spectrometry for the absolute quantification of proteins and peptides.

Authors:  Leah G Luna; Tracie L Williams; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2008-03-19       Impact factor: 6.986

4.  Implications of the emergence of a novel H1 influenza virus.

Authors:  Robert B Belshe
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

5.  Purification of large quantities of influenza virus by density gradient centrifugation.

Authors:  C B Reimer; R S Baker; R M Van Frank; T E Newlin; G B Cline; N G Anderson
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

6.  Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.

Authors:  C B Bridges; W W Thompson; M I Meltzer; G R Reeve; W J Talamonti; N J Cox; H A Lilac; H Hall; A Klimov; K Fukuda
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

7.  Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.

Authors:  Tracie L Williams; Leah Luna; Zhu Guo; Nancy J Cox; James L Pirkle; Ruben O Donis; John R Barr
Journal:  Vaccine       Date:  2008-05-12       Impact factor: 3.641

8.  Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection.

Authors:  Virginia García-Cañas; Barry Lorbetskie; Diane Bertrand; Terry D Cyr; Michel Girard
Journal:  Anal Chem       Date:  2007-03-16       Impact factor: 6.986

9.  Antibody recognition of a highly conserved influenza virus epitope.

Authors:  Damian C Ekiert; Gira Bhabha; Marc-André Elsliger; Robert H E Friesen; Mandy Jongeneelen; Mark Throsby; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

Review 10.  Emergence and pandemic potential of swine-origin H1N1 influenza virus.

Authors:  Gabriele Neumann; Takeshi Noda; Yoshihiro Kawaoka
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

View more
  17 in total

Review 1.  Novel vaccines against influenza viruses.

Authors:  S M Kang; J M Song; R W Compans
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

2.  Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.

Authors:  Caroline Gravel; Changgui Li; Junzhi Wang; Anwar M Hashem; Bozena Jaentschke; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  J Vis Exp       Date:  2011-04-04       Impact factor: 1.355

3.  Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine.

Authors:  Changgui Li; Kangwei Xu; Anwar Hashem; Ming Shao; Shuzhen Liu; Yong Zou; Qiang Gao; Yongchao Zhang; Liyong Yuan; Miao Xu; Xuguang Li; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

Authors:  Susan M Twine; Kelly M Fulton; John Spika; Marc Ouellette; Jennifer F Raven; J Wayne Conlan; Lakshmi Krishnan; Luis Barreto; James C Richards
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

6.  MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.

Authors:  James S Testa; Vivekananda Shetty; Julie Hafner; Zacharie Nickens; Shivali Kamal; Gomathinayagam Sinnathamby; Ramila Philip
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.

Authors:  Rongmao Zhao; Shujuan Cui; Li Guo; Chao Wu; Richard Gonzalez; Gláucia Paranhos-Baccalà; Guy Vernet; Jianwei Wang; Tao Hung
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

Review 8.  Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDC.

Authors:  Zhenglun Liang; Qunying Mao; Yiping Wang; Changgui Li; Kai Gao; Junzhi Wang
Journal:  Emerg Microbes Infect       Date:  2014-09-17       Impact factor: 7.163

9.  A novel synthetic receptor-based immunoassay for influenza vaccine quantification.

Authors:  Anwar M Hashem; Caroline Gravel; Aaron Farnsworth; Wei Zou; Michelle Lemieux; Kangwei Xu; Changgui Li; Junzhi Wang; Marie-France Goneau; Maria Merziotis; Runtao He; Michel Gilbert; Xuguang Li
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

Review 10.  Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.

Authors:  Christine M Thompson; Emma Petiot; Alexandre Lennaertz; Olivier Henry; Amine A Kamen
Journal:  Virol J       Date:  2013-05-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.